M. Kroll and R. Elin, Interference with clinical laboratory analyses, Clin Chem, vol.40, 1994.

A. Vassault, D. Grafmeyer, J. Graeve, . De, R. Cohen et al., Analyses de biologie médicale : spécifications et normes d'acceptabilité à l'usage de la validation de techniques, Ann Biol Clin, vol.57, issue.6, pp.685-95, 1999.

R. Bais, The Effect of Sample Hemolysis on Cardiac Troponin I and T Assays, Clinical Chemistry, vol.56, issue.8, pp.1357-1359, 2010.
DOI : 10.1373/clinchem.2010.144139

B. Hainque, B. Baudin, and P. Lefebvre, Appareils et méthodes en biochimie et biologie moléculaire, Medecine-Science. Flammarion, 2008.

J. Beaudeux and G. Durand, Biochimie médicale. Marqueurs actuels et perspectives

M. Piketty, F. Lancelin, E. Poirier-bègue, D. Guillouzic, and . Le, Pièges analytiques en hormonologie thyroïdienne, MTE, vol.2, issue.4, pp.311-333, 2000.

C. Kaitwatcharachai, S. Kaitwatcharachai, J. Aeden, and D. Wiriyasombat, The glucose interference in creatinine measurement using an enzymatic method: effect of creatinine concentrations, J Med Assoc Thail, vol.94, pp.131-134, 2011.

C. Émile, Interférences médicamenteuses sur les résultats en immunoanalyse, Option Bio, vol.20, issue.413, pp.16-17, 2009.

G. Siest, J. Henny, and F. Schiele, Référence en biologie clinique 11. Sonntag O, Scholer A. Drug interference in clinical chemistry: recommendation of drugs and their concentrations to be used in drug interference studies, Ann Clin Biochem, vol.38, pp.376-385, 1990.

C. Kesavachandran, F. Haamann, A. Nienhaus, E. Rouwet, and H. Russcher, Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis):e55364. 14. Young DS. Effects of drugs on clinical laboratory tests Interference of ethylene glycol with (L)-lactate measurement is assay-dependentLactate Dehydrogenase Interference with an Enzymatic Alcohol Analysis, Sapin R. Interférences dans les immunodosages : mécanismes et conséquences en endocrinologie70?72. 16. Powers RH, Dean DE. Evaluation of Potential Lactate, pp.561-563, 2000.

H. Malandain and Y. Cano, Place des techniques enzymatiques dans le diagnostic et le suivi des intoxications par un alcool ou un glycol, Toxicorama, vol.6, issue.4, 1999.

J. Schifferli, P. Roth, G. Steiger, J. Paccaud, and M. Schmidt, Macro-prostatic acid phosphatase in a patient's serum):2172?2174. 19. Klonoff DC. Macroamylasemia and other immunoglobulin-complexed enzyme disorders, Clin Chem. West J Med. Adv Clin Chem, vol.3413320, issue.20, pp.267-286, 1978.

K. Adachi, K. Suzuki, Y. Ohno, B. Sato, J. Murros et al., Impaired amylase activities caused by binding of abnormal immunoglobulin A in patients with macroamylasemia A new cause of increased serum aspartate aminotransferase activity Immunoglobulin-complexed aspartate aminotransferase Immunoglobulin A (lambda chains) conjugated with lactate dehydrogenase in serum, 103?113. 22. Konttinen A, pp.1085-1086, 1978.

J. Mishler and G. Dürr, Macroamylasemia Induced by Hydroxyethyl Starch ??? Confirmation by Gel Filtration Analysis of Serum and Urine, 387?391. 26. Köhler H, Kirch W, Horstmann HJ. Hydroxyethyl starch-induced macroamylasemia, 1980.
DOI : 10.1093/ajcp/74.4.387

H. Ihara, Y. Aoki, Y. Saito, T. Aoki, D. B. Douglas et al., Macro-creatine kinase type 1 possibly induced by intravenous hyperalimentation Development of macro-aspartate aminotransferase in a patient undergoing specific allergen injection immunotherapy Exploration d'une augmentation isolée de l'aspartate aminotransférase chez une patiente traitée par la minocycline : mise en évidence d'une macroenzyme Immunoglobulinassociated creatine kinase masquerading as macro-creatine kinase type 2 in a statin user, 109?110. 28. Triester SL1061?1064. 31. Wilding P, Cooke W, Nicholson I. Globulin-bound amylase: a cause of persistently Elevated Levels in Serum. Ann Int Med, pp.1053-1062, 1964.

P. Wilding, M. Geokas, B. Haverback, and D. Stanworth, Hyperamylasemia due to protein-bound amylase, The American Journal of Medicine, vol.47, issue.3, pp.492-496, 1969.
DOI : 10.1016/0002-9343(69)90233-2

J. Berk, H. Kizu, P. Wilding, and R. Searcy, Macroamylasemia: a newly recognized cause for elevated serum amylase activity):941?946. 34. Lundh B. A macromolecular serum lactate dehydrogenase activity in a case of leukemia, N Engl J Med. Clin Chim Acta, vol.27716, issue.182, pp.305-309, 1967.

P. Ganrot, Lupoid cirrhosis with serum lactic acid dehydrogenase linked to an ??A immunoglobulin, Experientia, vol.11, issue.7, p.593, 1967.
DOI : 10.1007/BF02137992

M. Nagamine and S. Okuma, Serum alkaline phosphatase isoenzymes linked to immunoglobulin G):39?46. 37. Remaley AT, Wilding P. Macroenzymes: biochemical characterization, clinical significance, and laboratory detection, Clin Chim Acta. Clin Chem, vol.6535, issue.112, pp.2261-2270, 1975.

T. Mifflin, D. Bruns, U. Wrotnoski, R. Macmillan, R. Stallings et al., University of Virginia case conference. Macroamylase, macro creatine kinase, and other macroenzymes Macro enzymes: prevalence, composition, detection and clinical relevance, 65?81. 40. Levitt MD, Cooperband SR. Hyperamylasemia from the binding of serum amylase by an 11S IgA globulin, pp.474-479, 1968.

T. Tomasi, . Jr, and S. Hauptman, The binding of alpha-1 antitrypsin to human IgA, J Immunol Baltim Md, vol.112, issue.6, pp.2274-2277, 1974.

C. Laurell, E. Thulin, K. Fujita, I. Sakurabayashi, M. Kusanagi et al., 1-antitrypsin respectively prealbumin A lactate dehydrogenaseimmunoglobulin G1 complex, not blocked by anti-idiotype antibody, in a patient with IgG1-lambda type M-proteinemia Atypical LD isoenzymes with five diffuse bands and evidence for two types of binding Affinity characteristics of amylase-binding substance(s) prepared from macroamylase complexes Macro lipase--a new member of the family of immunoglobulin-linked enzymes, 37?44. 45. Fridhandler L, pp.22-25, 1974.

T. Moriyama, T. Ashiie, K. Kikuiri, Y. Nishiyama, Y. Ito et al., Mitochondrial aspartate aminotransferase linked to immunoglobulin G of the kappalambda type: report of a case Intestinal alkaline phosphatase linked to immunoglobulin G of the kappa type Demonstration of antibody for glutamic pyruvic transaminase (GPT) in chronic hepatic disorders, Clin Chim Acta. Clin Chim Acta. Clin Chim Acta, vol.16013589, issue.313, pp.485-492, 1978.

P. Crofton, Site of alkaline phosphatase attachment in alkaline phosphatase-immunoglobulin G complexes, Clinica Chimica Acta, vol.112, issue.1, pp.33-42, 1981.
DOI : 10.1016/0009-8981(81)90266-7

T. Moriyama, T. Takebe, M. Nobuoka, and M. Makino, Characterization of amylase linked immunoglobulin G to distinguish human salivary and pancreatic isoamylases, Clinica Chimica Acta, vol.174, issue.1, pp.25-33, 1988.
DOI : 10.1016/0009-8981(88)90364-6

T. Kanno, K. Sudo, S. Landaas, P. Kierulf, and J. Strømme, Properties of amylase-linked immunoglobulins):67?77. 53. Cepelak I, Cvoriscec D. Why is it necessary to recognize macroenzymes? Macroamylase immunoglobulins show high affinity for animal and human amylases, 52?9. 54. Urdal P, pp.699-702, 1977.

P. Urdal, . Macro-creatine-kinase-bb-isoenzyme-in-serum, K. Sudo, K. Iwahara, T. Kanno et al., most likely an antigenautoantibody complex Lactate dehydrogenase inhibition by immunoglobulin G in human serum Macro lactate dehydrogenase: an LDHimmunoglobulin M complex that inhibits lactate dehydrogenase activity in a patient's serum, ):499?505. 56. Maekawa M):183?195. 58. Yasmineh WG, pp.1347-1349, 1981.

L. Turecky, Macroenzymes and their clinical significance, Bratisl Lekárske Listy, vol.105, issue.78, pp.260-263, 2004.

Y. Artur, G. Sanderink, and M. I. , Les macroenzymes dans le plasma humain, 2ème partie. Macrogamma-glutamyltransférase, macroalanine aminopeptidase, macrophosphatase alcaline, macroaminotransférases et autres macroenzymes, Ann Biol Clin, vol.45, issue.3, pp.277-284, 1987.

J. Schifferli, J. Despont, A. Cruchaud, N. Carpentier, M. Jeannet et al., Macrocreatine kinase type 1. Immunological studies in 14 patients with comments on clinical significance, Arch Pathol Lab Med. Clin Chim Acta, vol.110159, issue.51, pp.17-25, 1986.

H. Zimmerman, S. Bank, P. Buch, I. Katzka, and S. Lendvai, Macroamylase in the pleural fluid of a patient with lymphoma, Gastroenterology, vol.85, issue.1, pp.190-193, 1983.

T. Tomasi, E. Tan, A. Solomon, and R. Prendergast, CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS, Journal of Experimental Medicine, vol.121, issue.1, pp.101-124, 1965.
DOI : 10.1084/jem.121.1.101

J. Delanghe, D. Buyzere, M. , D. Scheerder, I. Vanderborght et al., Macro-lactate dehydrogenase in serum after acute myocardial infarction, Clin Chem, vol.33, issue.6, pp.1103-1104, 1987.

J. Delanghe, D. Scheerder, I. , D. Buyzere, M. Algoed et al., Macro CK type 1 as a marker for autoimmunity in coronary heart disease Abnormal patterns of lactate dehydrogenase isoenzymes after streptokinase therapy, 2210. 68. Podlasek SJ, pp.527-532, 1985.

A. Wu, V. Herson, G. Bowers, and . Jr, Macro creatine kinase types 1 and 2: clinical significance in neonates and children as compared with adults, Clin Chem, vol.29, issue.1, pp.201-204, 1983.

W. Stein, J. Bohner, M. Bahlinger, D. Brdiczka, D. Jahnke et al., Analytical patterns and biochemical properties of macro creatine kinase type 2 Octamerdimer transitions of mitochondrial creatine kinase in heart disease, 1952?1958. 71. Soboll S857?866. 72. Schlattner U, Wallimann T. Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding, pp.17314-17320, 1985.

H. Lang and U. Würzburg, Creatine kinase, an enzyme of many forms):1439?1447. 74. Crofton PM, Smith AF. High-molecular-mass alkaline phosphatase in serum and bile: physical properties and relationship with other high-molecular-mass enzymes, Clin Chem. Clin Chem, vol.2827, issue.76, pp.860-866, 1981.

N. Huseby, Multiple forms of serum ??-glutamyltransferase. Association of the enzyme with lipoproteins, Clinica Chimica Acta, vol.124, issue.1, pp.103-112, 1982.
DOI : 10.1016/0009-8981(82)90324-2

D. Broe, M. Borgers, M. Wieme, and R. , The separation and characterization of liver plasma membrane fragments circulating in the blood of patients with cholestasis, Clinica Chimica Acta, vol.59, issue.3, pp.369-372, 1975.
DOI : 10.1016/0009-8981(75)90013-3

M. Levitt, Clinical use of amylase clearance and isoamylase measurements, Mayo Clin Proc, vol.54, issue.7, pp.428-431, 1979.

R. T. Sapin, I. Vlahos, W. Macmahon, D. Sgoutas, W. Bowers et al., Article 90-10-0900]. 79 An improved ultrafiltration method for determining free testosterone in serum, Clin Chem, vol.28, issue.11, pp.1-02286, 1982.

J. Guéchot, J. Fiet, S. Wyness, J. Hunsaker, S. La-'ulu et al., Detection of macrocreatine kinase and macroamylase by polyethylene glycol precipitation and ultrafiltration methods The detection of macroprolactin by precipitation and ultrafiltration methods A practical method for the detection of macroprolactinaemia using ultrafiltration Reference intervals for six enzymes after polyethylene glycol precipitation and ultrafiltration, Dosage de la testostérone plasmatique : difficultés méthodologiques et intérêt physiopathologique529?536. 83. Prazeres S, pp.23-24686, 2003.

D. Davidson and D. Watson, Macroenzyme detection by polyethylene glycol precipitation, Annals of Clinical Biochemistry, vol.40, issue.5, pp.514-520, 2003.
DOI : 10.1258/000456303322326425

URL : http://journals.sagepub.com/doi/pdf/10.1258/000456303322326425

T. Henning, X. Thomas, G. Cannas, Y. Chelghoum, and A. Gougounon, Polyethylene glycols (PEGs) and the pharmaceutical industry Alternatives thérapeutiques à la L-asparaginase native dans le traitement de la leucémie aiguë lymphoblastique de l'adulte, 1105?1117. 88. Macquin-Mavier I, Hezode C, Dhumeaux D. Les interférons pégylés : bases pharmacologiques, pp.742-789, 2001.

R. Wener, F. Loupatty, and W. Schouten, Isolated elevated aspartate aminotransferase: a surprising outcome for clinicians, Neth J Med, vol.70, issue.3, pp.136-138, 2012.

C. Coussieu, C. Briggs, D. Anderson, P. Johnson, and T. Deegan, Prolactine, 41?49. 91, pp.177-181, 1981.
DOI : 10.1016/S2211-9698(06)76496-2

R. George, M. Wallage, and R. Goodall, The use of trypsin to confirm the presence of macrocreatine kinase on isoenzyme electrophoresis, Annals of Clinical Biochemistry, vol.49, issue.4, pp.359-362, 2012.
DOI : 10.1258/acb.2011.011175

J. Lagabrielle, B. Bonnefoy, S. Vergnaud, V. Boin, and A. Tachet, Une « cytolyse hépatique chronique » : découverte d'une macro-ASAT Laboratory detection of macroaspartate aminotransferase: case report and evaluation of the PEG-precipitation method, 179?182. 94. Patteet L, Simoens M, Piqueur M, Wauters A, pp.691-693, 2008.

J. Buttery, C. Milner, P. Nenadovic, and P. Pannall, Detection of alkaline phosphatase/immunoglobulin complexes, Clin Chem, vol.26, issue.11, pp.1620-1621, 1980.

K. Bauer, P. Bayer, E. Deutsch, and F. Gabl, Binding of enzyme--IgG complexes in human serum to Protein-A Sepharose CL-4B, Clin Chem, vol.26, issue.2, pp.297-300, 1980.

K. Hocchi, T. Ohashi, T. Miura, K. Sasagawa, Y. Sato et al., Development of an ELISA method for detecting immune complexes between tissue-nonspecific alkaline phosphatase and immunoglobulin G, Journal of Clinical Laboratory Analysis, vol.321, issue.5, pp.322-329, 2007.
DOI : 10.1042/bj3210297

D. Davidson and J. Scott, Detection of creatine kinase macroenzymes, Annals of Clinical Biochemistry, vol.49, issue.5, pp.482-485, 2012.
DOI : 10.1258/acb.2012.011270

M. Fahie-wilson and D. Halsall, Polyethylene glycol precipitation: proceed with care, Annals of Clinical Biochemistry, vol.45, issue.3, pp.233-235, 2008.
DOI : 10.1258/acb.2008.007262

URL : http://journals.sagepub.com/doi/pdf/10.1258/acb.2008.007262

E. Etienne, A. Hanser, B. Woehl-kremer, M. Mohseni-zadeh, G. Blaison et al., Macroenzymes??: macro-ASAT et macro-CPK. Deux observations et revue de la litt??rature, La Revue de M??decine Interne, vol.30, issue.11, pp.963-969, 2009.
DOI : 10.1016/j.revmed.2009.06.008

J. Cabrera-abreu, R. Jain, P. Robinson, S. Edees, and T. Staughton, A case of aspartate aminotransferase macroenzyme, Annals of Clinical Biochemistry, vol.45, issue.3, pp.320-322, 2008.
DOI : 10.1258/acb.2007.007063

R. Orlando, A. Carbone, and F. Lirussi, Macro-aspartate aminotransferase (macro-AST). A 12-year follow-up study in a young female, European Journal of Gastroenterology & Hepatology, vol.15, issue.12, pp.1371-1373, 2003.
DOI : 10.1097/00042737-200312000-00018

D. Sass, R. Chadalavada, and M. Virji, Unexplained Isolated Elevation in Serum Aspartate Aminotransferase: Think Macro!, The American Journal of Medicine, vol.120, issue.9, pp.5-6, 2007.
DOI : 10.1016/j.amjmed.2006.10.022

K. Sudo, M. Maekawa, H. Watanabe, K. Matsumoto, Y. Mori et al., A case of immunoglobulin G conjugated with lactate dehydrogenase, producing both loss of enzyme activity and an abnormal isoenzyme pattern, Clin Chem, vol.32, issue.7, pp.1420-1422, 1986.

G. Wickus and M. Smith, Rapid loss of lactate dehydrogenase isoenzyme activity in serum by cold-induced formation of immunoglobulin G-lactate dehydrogenase complex, Clin Chem, vol.30, issue.1, pp.11-17, 1984.

H. Nakagawa, K. Umeki, K. Yamanaka, N. Kida, and S. Ohtaki, Macromolecular alkaline phosphatase and an immunoglobulin G that inhibited alkaline phosphatase in a patient's serum, Clin Chem, vol.29, issue.2, pp.375-378, 1983.

K. Lee, G. Csako, P. Bernhardt, and R. Elin, Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data, Clin Chem, vol.40, issue.7, pp.1278-1283, 1994.

W. Stein, J. Bohner, W. Renn, and R. Maulbetsch, Macro creatine kinase type 2: results of a prospective study in hospitalized patients, Clin Chem, vol.31, issue.12, 1985.

T. Hoshino, Y. Sakai, K. Yamashita, K. Kishi, K. Tanjoh et al., Clinical Evaluation of a New Creatine Kinase MB Activity Reagent Abrogating the Effect of Mitochondrial Creatine Kinase, Clinical Laboratory, vol.59, issue.03+04/2013, pp.3-4307, 2013.
DOI : 10.7754/Clin.Lab.2012.120516

D. Watanabe, M. Yoshino, H. Yagura, K. Hirota, H. Yonemoto et al., Increase in serum mitochondrial creatine kinase levels induced by tenofovir administration, Journal of Infection and Chemotherapy, vol.18, issue.5, pp.675-682, 2012.
DOI : 10.1007/s10156-012-0393-8

H. Recommandation, Rapport -Evaluation de l'amylasémie et de la lipasémie pour le diagnostic initial de la pancréatite aiguë, 2009.

J. Lott, E. Ellison, and D. Applegate, The importance of objective data in the diagnosis of pancreatitis, Clinica Chimica Acta, vol.183, issue.1, pp.33-40, 1989.
DOI : 10.1016/0009-8981(89)90269-6

N. Yanagitani, K. Kaira, N. Sunaga, Y. Naito, Y. Koike et al., Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer?, International Journal of Clinical Oncology, vol.7, issue.3, pp.231-233, 2007.
DOI : 10.2482/haigan.43.715

T. Oita, A. Yamashiro, F. Mizutani, A. Tamura, K. Sakizono et al., Simultaneous presence of macroamylase and macrolipase in a patient with celiac disease

P. Bernades, M. Corbic, J. Jardillier, N. Schlegel, R. Dupuy et al., Rapport de trios nouveaux cas, Arch Fr Mal App Dig, vol.64, issue.1, pp.47-52, 1975.

J. Touboul, P. Hadchouel, H. Hirsh-marie, J. Caroli, and R. H. , Macroamylasémie associée à une malabsorption et une cryoglobulinémie Etude clinique et biologique d'un nouveau cas, Médecine Chir Dig, vol.3, issue.6, pp.419-426, 1974.

G. Leroux-roels, R. Wieme, and M. De-broe, Occurrence of enzyme-immunoglobulin complexes in chronic inflammatory bowel disease, J Lab Clin Med, vol.97, issue.3, pp.316-321, 1981.

P. Crofton, D. Kilpatrick, and A. Leitch, Complexes in serum between alkaline phosphatase and immunoglobulin G: immunological and clinical aspects, Clinica Chimica Acta, vol.111, issue.2-3, pp.2-3257, 1981.
DOI : 10.1016/0009-8981(81)90193-5

T. Tozawa, Electrophoretic analysis of enzyme-linked immunoglobulins and their clinical significance, Journal of Chromatography B: Biomedical Sciences and Applications, vol.569, issue.1-2, pp.347-365, 1991.
DOI : 10.1016/0378-4347(91)80237-7

P. Galasso, S. Litin, O. Brien, and J. , The Macroenzymes: A Clinical Review, Mayo Clinic Proceedings, vol.68, issue.4, pp.349-354, 1993.
DOI : 10.1016/S0025-6196(12)60129-3

P. Lang, S. Govind, R. Aspinall, and . L-'immunosénescence, L???immunos??nescence, NPG Neurologie - Psychiatrie - G??riatrie, vol.12, issue.70, pp.171-181, 2012.
DOI : 10.1016/j.npg.2012.04.005

J. Perez-calle, I. Marin-jimenez, P. Lopez-serrano, J. Gisbert, A. Pena et al., Prevalence of Macrocreatinkinase Type 1 in Patients with Inflammatory Bowel Disease, Digestive Diseases and Sciences, vol.26, issue.5, pp.486-489, 2008.
DOI : 10.1016/S0300-8932(97)73199-3

M. Caropreso, G. Fortunato, S. Lenta, D. Palmieri, M. Esposito et al., Prevalence and Long-term Course of Macro-Aspartate Aminotransferase in Children, The Journal of Pediatrics, vol.154, issue.5, pp.744-748, 2009.
DOI : 10.1016/j.jpeds.2008.11.010

R. Weijers, O. Elferink, R. Mulder, J. Kruijswijk, and H. , Characterization of immunoglobulin A kappa autoantibodies to human lactate dehydrogenase

C. Bode, J. Riederer, B. Brauner, and J. Bode, Macrolipasemia: a rare cause of persistently elevated serum lipase, Am J Gastroenterol, vol.85, issue.4, pp.412-416, 1990.

H. Yuu, S. Ishizawa, Y. Takagi, K. Gomi, O. Senju et al., Macro creatine kinase: a study on CK-linked immunoglobulin, Clin Chem, vol.26, issue.13, pp.1816-1820, 1980.

P. Whelan and H. Malkus, A macro creatine kinase isoenzyme in serum of apparently healthy individuals, Clin Chem, vol.29, issue.7, pp.1411-1414, 1983.

A. Wu, G. Bowers, and . Jr, Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals, Clin Chem, vol.28, issue.10, pp.2017-2021, 1982.

S. Sax, J. Moore, J. Giegel, and M. Welsh, Further observations on the incidence and nature of atypical creatine kinase activity, Clin Chem, vol.25, issue.4, pp.535-541, 1979.

J. Bohner, W. Stein, R. Steinhart, U. Würzburg, and M. Eggstein, Macro creatine kinases: results of isoenzyme electrophoresis and differentiation of the immunoglobulin-bound type by radioassay, Clin Chem, vol.28, issue.4, pp.618-623, 1982.

P. Dingjan, T. Postma, and J. Stroes, The diagnostic value of certain alkaline phosphatase isoenzyme patterns in human serum, fractions obtained by polyacrylamide disc electrophoresis, Clinica Chimica Acta, vol.60, issue.2, pp.169-183, 1975.
DOI : 10.1016/0009-8981(75)90122-9

Y. Hattori, K. Yamamoto, C. Urabe, M. Furuya, H. Eguchi et al., Frequency of alkaline phosphatase???immunoglobulin complex among diseased and healthy populations, Clinica Chimica Acta, vol.147, issue.2, pp.155-158, 1985.
DOI : 10.1016/0009-8981(85)90076-2

G. Lawson, Prevalence of macroamylasaemia using polyethylene glycol precipitation as a screening method, Annals of Clinical Biochemistry, vol.38, issue.1, pp.37-45, 2001.
DOI : 10.1258/0004563011900263

R. Forsman, Macroamylase: Prevalence, distribution of age, sex, amylase activity, and electrophoretic mobility, Clinical Biochemistry, vol.19, issue.4, pp.250-253, 1986.
DOI : 10.1016/S0009-9120(86)80036-4

H. Schmid, D. Mühlbayer, J. Röling, T. Sternfeld, B. Jülg et al., Macroenzyme creatine kinase (CK) type 2 in HIV-infected patients is significantly associated with TDF and consists of ubiquitous mitochondrial CK, Antivir Ther, vol.11, issue.8, pp.1071-1080, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00390894

K. Okano, K. Yamamoto, Y. Ohba, K. Matsumura, and T. Miyaji, Source of elevated serum mitochondrial creatine kinase activity in patients with malignancy, Clinica Chimica Acta, vol.169, issue.2-3, pp.2-3159, 1987.
DOI : 10.1016/0009-8981(87)90315-9

H. Nakagawa, N. Kida, M. Maesa, Y. Wakuta, and S. Ohtaki, An abnormal isoenzyme of creatine kinase in the serum of a patient with metastatic carcinoma: identity with mitochondrial creatine kinase, Clin Chem, vol.28, issue.4, pp.723-725, 1982.

D. Mercer and T. Talamo, Multiple markers of malignancy in sera of patients with colorectal carcinoma: preliminary clinical studies, Clin Chem, vol.31, issue.11, pp.1824-1828, 1985.

S. Wright and N. Liggett, Elevation of creatine kinase as a marker of malignancy, Ir Med J, vol.96, issue.7, p.217, 2003.

P. Wenham, D. Horn, and A. Smith, Physical properties of ??-glutamyltransferase in human serum, Clinica Chimica Acta, vol.141, issue.2-3, pp.205-218, 1984.
DOI : 10.1016/0009-8981(84)90012-3

P. Wenham, D. Horn, and A. Smith, Multiple forms of gamma-glutamyltransferase: a clinical study, Clin Chem, vol.31, issue.4, pp.569-573, 1985.

L. Turecký, V. Kupcová, K. Laktis, E. Uhlíková, and M. Szántová, Use of gamma glutamyltransferase isoenzymes in the differentiation of chronic liver diseases [Abstract], Bratisl Lek Listy, vol.98, issue.3, pp.137-140, 1997.

S. Take, L. Fridhandler, and J. Berk, Macroamylasemia: possible role of polysaccharide in composition of macroamylase, Clin Chim Acta, vol.27, issue.2, pp.369-371, 1970.

M. Omar, J. Wilson, and T. Cox, Rhabdomyolysis and HMG-CoA Reductase Inhibitors, Annals of Pharmacotherapy, vol.21, issue.9
DOI : 10.1345/aph.18291

P. Dorosz, Guide pratique des médicaments. 25 ième édition. Maloine, pp.974-77, 2005.

F. Authier, C. P. Gherardi, and R. , Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART), Muscle & Nerve, vol.53, issue.3, pp.247-260, 2005.
DOI : 10.1212/WNL.53.2.386

A. Elhayany, R. Mishaal, and S. Vinker, Is there clinical benefit to routine enzyme testing of patients on statins?, Expert Opinion on Drug Safety, vol.106, issue.6, pp.185-190, 2012.
DOI : 10.1001/jama.289.13.1681

T. Piscopo, P. Mcdonald, and A. Miller, Serum creatine phosphokinase monitoring in patients infected with HIV, International Journal of STD & AIDS, vol.17, issue.1, pp.61-62, 2006.
DOI : 10.1258/095646206775220487

G. Schumann, R. Bonora, F. Ceriotti, P. Clerc-renaud, C. Ferrero et al., IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 2. Reference procedure for the measurement of catalytic concentration of creatine kinase, Clin Chem Lab Med, vol.40, issue.6, pp.635-642, 2002.

K. Thygesen, J. Mair, H. Katus, M. Plebani, P. Venge et al., Recommendations for the use of cardiac troponin measurement in acute cardiac care, European Heart Journal, vol.55, issue.1, pp.312197-2204, 2010.
DOI : 10.1373/clinchem.2008.117218

A. Wu, F. Apple, W. Gibler, R. Jesse, M. Warshaw et al., National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases, Clin Chem, vol.45, issue.7, pp.1104-1121, 1999.

M. Pudek and B. Jacobson, Falsely negative laboratory diagnosis for myocardial infarction owing to the concurrent presence of macro creatine kinase and macro lactate dehydrogenase, Clin Chem, vol.28, issue.12, pp.2434-2437, 1982.

A. Levey, J. Bosch, J. Lewis, T. Greene, N. Rogers et al., A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation, Annals of Internal Medicine, vol.130, issue.6, pp.461-470, 1999.
DOI : 10.7326/0003-4819-130-6-199903160-00002

C. Tsai, K. Follis, A. Sabo, T. Beck, R. Grant et al., Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphonylmethoxypropyl)adenine, Science, vol.270, issue.5239, pp.1197-1199, 1995.
DOI : 10.1126/science.270.5239.1197

C. Perry and D. Simpson, Tenofovir Disoproxil Fumarate, Drugs, vol.44, issue.2, pp.2245-2256, 2009.
DOI : 10.2165/10482940-000000000-00000

H. Fung, E. Stone, and F. Piacenti, Tenofovir disoproxil fumarate: A nucleotide reverse transcriptase inhibitor for the treatment of HIV infection, Clinical Therapeutics, vol.24, issue.10, pp.1515-1548, 2002.
DOI : 10.1016/S0149-2918(02)80058-3

M. Nelson, C. Katlama, J. Montaner, D. Cooper, B. Gazzard et al., The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years, AIDS, vol.21, issue.10, pp.1273-1281, 2007.
DOI : 10.1097/QAD.0b013e3280b07b33

K. Woratanarat, T. Kanjanabuch, and C. Suankratay, Tenofovir disoproxil fumarateassociated nephrotoxicity in HIV-infected patients: a prospective controlled study, J Med Assoc Thail, vol.96, issue.4, pp.432-439, 2013.

S. Becker, P. Ruane, and P. Cimoch, Safety profile of tenofovir disoproxil fumarate in patients with advanced HIV disease. Program and abstracts of the 41st Interscience Conference on, Antimicrobial Agents and Chemotherapy, vol.16, 2001.

S. Badre-sentenac, Int??r??t du suivi th??rapeutique des antir??troviraux chez le patient insuffisant r??nal: Exemple du t??nofovir, Revue Fran??aise des Laboratoires, vol.2004, issue.365, pp.73-81, 2008.
DOI : 10.1016/S0338-9898(04)80209-9

C. Tsoukas and N. Bernard, Markers predicting progression of human immunodeficiency virus-related disease., Clinical Microbiology Reviews, vol.7, issue.1, pp.14-28, 1994.
DOI : 10.1128/CMR.7.1.14

H. Schmid, M. Tokarska-schlattner, B. Füeßl, M. Röder, L. Kay et al., Macro CK2 accumulation in tenofovir-treated HIV patients is facilitated by CK oligomer stabilization but is not predictive for pathology, Antiviral Therapy, vol.18, issue.2, pp.193-204, 2013.
DOI : 10.3851/IMP2313

N. Jacob, I. Aimone-gastin, J. Arzouni, and C. Augereau, Développement professionnel continue et biologie médicale, Spectra biologie, pp.28-31, 0200.

D. Morrow, C. Cannon, R. Jesse, L. Newby, J. Ravkilde et al., National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes, Clin Chem, vol.53, issue.4, pp.552-574, 2007.

E. Wiltshire, M. Crooke, and K. Grimwood, Macro-AST: A benign cause of persistently elevated aspartate aminotransferase, Journal of Paediatrics and Child Health, vol.32, issue.11, pp.642-643, 2004.
DOI : 10.1016/0009-8981(90)90279-2

N. Schneider, K. Aakre, G. Thue, S. Sandberg, V. Durlach et al., Evaluation de la prescription et de l'interprétation des dosages de microalbuminurie en médecine générale, Ann Biol Clin, vol.67, issue.1, pp.47-53, 2009.

S. Skeie, C. Perich, C. Ricos, A. Araczki, A. Horvath et al., Postanalytical External Quality Assessment of Blood Glucose and Hemoglobin A1c: An International Survey, Clinical Chemistry, vol.51, issue.7, pp.1145-1153, 2005.
DOI : 10.1373/clinchem.2005.048488

R. Chasuk, P. Brantley, and P. Martin, Knowledge and attitudes of family physicians about clinical practice guidelines and the care of patients with type 2 diabetes mellitus

G. Schumann, R. Bonora, F. Ceriotti, G. Férard, C. Ferrero et al., IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase, Clin Chem Lab Med, vol.40, issue.7, pp.718-724, 2002.

G. Schumann, R. Bonora, F. Ceriotti, G. Férard, C. Ferrero et al., IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 5. Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase, Clin Chem Lab Med, vol.40, issue.7, pp.725-733, 2002.

E. Giannini, R. Testa, and V. Savarino, Liver enzyme alteration: a guide for clinicians, Canadian Medical Association Journal, vol.172, issue.3, pp.367-379, 2005.
DOI : 10.1503/cmaj.1040752

G. Aragon and Z. Younossi, When and how to evaluate mildly elevated liver enzymes in apparently healthy patients, Cleveland Clinic Journal of Medicine, vol.77, issue.3, pp.195-204, 2010.
DOI : 10.3949/ccjm.77a.09064

R. Green and S. Flamm, AGA technical review on the evaluation of liver chemistry tests, Gastroenterology, vol.123, issue.4, pp.1367-1384, 2002.
DOI : 10.1053/gast.2002.36061

D. Dufour, J. Lott, F. Nolte, D. Gretch, R. Koff et al., Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests, Clin Chem, vol.46, issue.12, pp.2027-2049, 2000.

L. Friedman, J. Dienstag, E. Watkins, C. Hinkle, J. Spiers et al., Evaluation of Blood Donors with Elevated Serum Alanine Aminotransferase Levels, Annals of Internal Medicine, vol.107, issue.2, pp.137-144, 1987.
DOI : 10.7326/0003-4819-107-2-137

J. Clark, F. Brancati, and A. Diehl, The prevalence and etiology of elevated aminotransferase levels in the United States, The American Journal of Gastroenterology, vol.107, issue.32, pp.960-967, 2003.
DOI : 10.1016/S0002-9343(99)00271-5

L. Fletcher, I. Kwoh-gain, E. Powell, L. Powell, and J. Halliday, Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: An aid to diagnosis, Hepatology, vol.24, issue.3, pp.455-459, 1991.
DOI : 10.1016/0016-5085(88)90183-7

G. Corrao, V. Bagnardi, A. Zambon, and P. Torchio, META-ANALYSIS OF ALCOHOL INTAKE IN RELATION TO RISK OF LIVER CIRRHOSIS, Alcohol and Alcoholism, vol.33, issue.4, pp.381-392, 1998.
DOI : 10.1093/oxfordjournals.alcalc.a008408

S. Omar, M. Feki, and N. Kaabachi, Le métabolisme du fer : revue générale et récents développements, Ann Biol Clin, vol.64, issue.6, pp.523-534, 2006.

T. Thevenot, P. Mathurin, D. Martino, V. Nguyen-khac, E. Canva-delcambre et al., Maladie coeliaque et atteinte hépatique, Gastroentérologie Clin Biol, vol.27, issue.1, pp.28-42, 2003.

M. Bardella, M. Vecchi, D. Conte, D. Ninno, E. Fraquelli et al., Chronic unexplained hypertransaminasemia may be caused by occult celiac disease, Hepatology, vol.12, issue.3, pp.654-657, 1999.
DOI : 10.1002/hep.510290318

URL : http://onlinelibrary.wiley.com/doi/10.1002/hep.510290318/pdf

B. Balkau, M. Charles, T. Drivsholm, K. Borch-johnsen, N. Wareham et al., Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome, Diabetes Metab, vol.28, issue.5, pp.364-376, 2002.

L. Fregonese and J. Stolk, Hereditary alpha-1-antitrypsin deficiency and its clinical consequences, Orphanet Journal of Rare Diseases, vol.3, issue.1, p.16, 2008.
DOI : 10.1186/1750-1172-3-16

URL : https://ojrd.biomedcentral.com/track/pdf/10.1186/1750-1172-3-16?site=ojrd.biomedcentral.com

O. Chazoullières, Hépatites auto-immunes : actualités. FMC-HGE. Post-U Paris, pp.17-25, 2004.

D. Gleeson and M. Heneghan, British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis, Gut, vol.60, issue.12, pp.1611-1629, 2011.
DOI : 10.1136/gut.2010.235259

F. Alvarez, P. Berg, F. Bianchi, L. Bianchi, A. Burroughs et al., International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis, Journal of Hepatology, vol.31, issue.5, pp.929-938, 1999.
DOI : 10.1016/S0168-8278(99)80297-9

A. Agin, F. Gasser, E. Fischbach, J. Schlienger, and R. Sapin, Estimation de la prolactine monom??rique apr??s pr??cipitation du s??rum au poly??thyl??ne glycol (PEG), Immuno-analyse & Biologie Sp??cialis??e, vol.19, issue.5, pp.301-305, 2004.
DOI : 10.1016/S0923-2532(04)00067-5

M. Levitt and C. Ellis, A rapid and simple assay to determine if macroamylase is the cause of hyperamylasemia, Gastroenterology, vol.83, issue.2, pp.378-382, 1982.

M. Fahie-wilson, S. Burrows, G. Lawson, T. Gordon, W. Wong et al., Prevalence of increased serum creatine kinase activity due to macro-creatine kinase and experience of screening programmes in district general hospitals, Annals of Clinical Biochemistry, vol.44, issue.4, pp.377-383, 2007.
DOI : 10.1258/000456307780945642

R. B. Aimo-ct...-".., @. .. Le_-'~o-w,-'c.-m, and ~. , Il ~ 1I, fr. n çois ~ Sarb~ , Ch ris t Gasti n' An unusual interference in CK MB assay caused bya macro enzyme creatine phosphokinase (CK) type 2 in HIV-infected patients K ~_ ," 1oc ~ !1>10: II I v, Annexe, vol.1

·. M~-oc-'''i\ur«, !. , and S. Boole, I,lti "" of '110 cr·M ,u,""I" "''''1' , _ ex 10 > 1<6 Ull ~ m piS'l llIa Mos' of!h . ti, poti ?? · .. wu" ex M S >1 Jo ? ? ..,. ' 0 '" dul. , ml'OC" ,jJ oIlrI" (jj "" (.I.Cfti. Aoo.1TW

K. , .. , F. , and C. M~, VllIc$>il W. w cte ' Uf)l,1o«! ., okm'. M<l uc'''li ~ iIl> lI<f1lrO cr, il! ou ~~~Ii"_ .,! lie lloIID, p.1

~. , S. Hlv·lnfocl«, !. , W. , ~. .. <l-'o-ex et al., I~' y (!!>«lIa " 18 1 l\"1: fall8' l . _fi() 1.\"1,) wlth "'~ of ex M ~ '0 .,Ia! a. j:>'ld jOl'o , Foo !'l'\Xl' 1Od I ~ , Ylie, lIe<n, vol.16, issue.1, pp.7-8

_. '100,..-".., oft lie .,Ia! a.: ",ti. ll\', il> ou . uly. !h . modJon ~ ' '''al ex

. H<r and . .. Of-'ho-poti..........-po-i, <!<IfS 1l (lIZj,o) h ad an . ffl d

U. .. Ül, !. 1>1110, and !. , bepl'I!!s Wu. ~wo JU. V ro .. bo.od Pl ~" " :>I d 'wo IIBV ... lrIoa04 p .. I ","~ AS'ilALY , .10 m04l) III ~ l paillots, 2001.

. Ity-o, of 1"", ' l'eXy.1o l' l, ~. !! fou , pal

<. Bt, ?? Xapoitl_ 4allls ... louo .. il"" dam ' I' ", Ill

I. .. , !. ~-'ho-4, . 0<11, and . <>-cx.-~h...-pati.....-w......, IIldul04 i>l !ho NADIS" <0000, ? ? Hm, al04 ? l\'1>,01 band

~. .. No, _. <loi-'.-", . Ss-'.., . Çx-~-_, .. I. Çutll et al., !(;lffi) r4\ cL th

_. _. _-_-'". and ~. @bullet-@bullet..-., 11 _ 0

_. , ,. \~, and T. _. , 11

<. .. H-n-j,, 0: \MlÇI) ' n ?, pp.1-91

M. , ~. Ti>, and ~. .. , otO Re

L. 'examen-clinique-de-monsieur and L. , est sans particularité : il pèse 72 kgs pour une taille de 176 cm, IMC =, vol.23

L. Monsieur, ne prend ni médicaments, ni phytothérapies et n'est pas exposé à des toxiques particuliers lors de son activité professionnelle. Il ne consomme pas de drogues et estime que sa consommation d'alcool n'est pas excessive

D. Bibliographie-dufour, J. Lott, F. Nolte, D. Gretch, R. Koff et al., Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests, Clin Chem, issue.12, pp.462027-462076, 2000.

J. -cadranel, Élévation chronique des transaminases : hypertransaminasémie chronique. EMC -AKOS (Traité de Médecine), pp.1-8, 2011.

E. Giannini, R. Testa, and V. Savarino, Liver enzyme alteration: a guide for clinicians, Canadian Medical Association Journal, vol.172, issue.3, pp.367-79, 2005.
DOI : 10.1503/cmaj.1040752

URL : http://www.cmaj.ca/content/172/3/367.full.pdf

G. -aragon and Z. Younossi, When and how to evaluate mildly elevated liver enzymes in apparently healthy patients, Cleveland Clinic Journal of Medicine, vol.77, issue.3, pp.195-204, 2010.
DOI : 10.3949/ccjm.77a.09064

R. -green and S. Flamm, AGA Technical review on the evaluation of liver chemistry tests. gastroenterology, pp.1367-84, 2002.

W. -smellie, J. Forth, S. Ryder, M. Galloway, A. Wood et al., Best practice in primary care pathology: review 5, J Clin Pathol, issue.12, pp.591229-591266, 2006.

P. Kamath, Clinical Approach to the Patient With Abnormal Liver Test Results, Mayo Clinic Proceedings, vol.71, issue.11, pp.1089-94, 1996.
DOI : 10.4065/71.11.1089

K. -musana, S. Yale, and A. Abdulkarim, Tests of Liver Injury, Clinical Medicine & Research, vol.2, issue.2, pp.129-160, 2004.
DOI : 10.3121/cmr.2.2.129

J. Limdi and G. Hyde, Evaluation of abnormal liver function tests, Postgraduate Medical Journal, vol.79, issue.932, pp.307-319, 2003.
DOI : 10.1136/pmj.79.932.307

S. Omar, M. Feki, and N. Kaabachi, Le métabolisme du fer : revue générale et récents développements, Ann Biol Clin, vol.64, issue.6, pp.523-557, 2006.

D. -gleeson and M. Heneghan, British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis, Gut, vol.60, issue.12, pp.1611-1640, 2011.
DOI : 10.1136/gut.2010.235259

F. -alvarez, International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis, Journal of Hepatology, vol.31, issue.5, pp.929-93, 1999.
DOI : 10.1016/S0168-8278(99)80297-9

L. Dans-tous and . Cas, face à un résultat positif obtenu avec une technique de dépistage (PEG, UF), il convient de confirmer la présence d'une macroenzyme au moyen d'une

A. Bibliographie-remaley and P. Wilding, Macroenzymes: biochemical characterization, clinical significance, and laboratory detection, Clin Chem, vol.35, issue.12, pp.2261-70, 1989.

R. Wener, F. Loupatty, and W. Schouten, Isolated elevated aspartate aminotransferase: a surprising outcome for clinicians, Neth J Med, vol.2012, issue.703, pp.136-144

T. Mifflin, D. Bruns, U. Wrotnoski, R. Macmillan, R. Stallings et al., University of Virginia case conference. Macroamylase, macro creatine kinase, and other macroenzymes, Clin Chem, issue.10, pp.311743-311751, 1985.

D. Davidson and D. Watson, Macroenzyme detection by polyethylene glycol precipitation, Annals of Clinical Biochemistry, vol.40, issue.5, pp.514-534, 2003.
DOI : 10.1258/000456303322326425

URL : http://journals.sagepub.com/doi/pdf/10.1258/000456303322326425

S. Wyness, J. Hunsaker, S. La-'ulu, L. Rao, and W. Roberts, Detection of macro-creatine kinase and macroamylase by polyethylene glycol precipitation and ultrafiltration methods, Clinica Chimica Acta, vol.412, issue.23-24, pp.2052-2059, 1920.
DOI : 10.1016/j.cca.2011.01.023

S. Wyness, J. Hunsaker, S. La-'ulu, and W. Roberts, Reference intervals for six enzymes after polyethylene glycol precipitation and ultrafitration, Clin Chem Acta, pp.412-423, 2011.
DOI : 10.1016/j.cca.2010.11.005

L. Patteet, M. Simoens, M. Piqueur, and A. Wauters, Laboratory detection of macro-aspartate aminotransferase: Case report and evaluation of the PEG-precipitation method, Clinical Biochemistry, vol.45, issue.9, pp.691-694
DOI : 10.1016/j.clinbiochem.2012.03.004